Oncology Expert, Dr. Nathan Pennell of the Cleveland Clinic Taussig Cancer Institute, Joins Vial’s Oncology CRO Advisory Board
San Francisco, CA. November 1 2022 — Dr. Nathan Pennell of the Cleveland Clinic Taussig Cancer Institute has joined Vial’s Oncology CRO Advisory Board. Dr. Pennell will advise Vial on enhancing its Oncology CRO product and services. Nathan Pennell, MD, Ph.D., FASCO, is a Professor of Medicine and the Director of the Lung Cancer Medical Oncology Program at the […]
